Phenylacetate Induces Growth Inhibition and Apoptosis of Human Osteosarcoma Cells
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Purpose: Phenylacetate has potent antiproliferative effects in many malignant tumors. However, the exact mechanism as to how phenylacetate induces cell growth arrest remains unclear and very little is known about its effects on human osteosarcoma cells. In this study, we investigated whether phenylacetate is effective against two osteosarcoma cell lines (HOS and U-2 OS) in vitro. Materials and Methods: The viability of phenylacetate- treated cell lines was assessed by trypan blue exclusion assay, and the cell cycle distribution was measured by flow cytometry. To measure cell apoptosis, poly (ADP- ribose) polymerase cleavage assay and flow cytometry were employed. The expressions of cell cycle-regulatory proteins and the apoptosis-related genes were evaluated by western blot analysis. Results: Phenylacetate was found to inhibit the growth of osteosarcoma cells, induce cell cycle arrest in the G1 phase, and induce apoptosis. A significant decrease in Bcl-2 expression and a mild up-regulation of Bax were also observed in both phenylacetate-treated cell lines. Reduced phosphorylation of the pRb and the increased expression of p21Cip1 were observed subsequent to treatment with phenylacetate. Conclusion: These findings support the idea that phenylacetate may be an effective chemotherapeutic agent to be employed in the future against osteosarcoma, because phenylacetate acts to inhibit the growth of osteosarcoma cells through cell cycle arrest and apoptosis.(Cancer Res Treat. 2004;36:324-329)
참고문헌 (25)
- "Apreliminary report of neoadjuvant chemotherapy NSH-7 studyin osteosarcoma:preoperative salvage chemotherapy based onclinical tumor response and the use of granulocyte colony-stimulatingfactor", 53, pp.221~227 (1996)
- "Local and systemic control after ablative and limb sparingsurgery in patients with osteosarcoma", 358, pp.120~127 (1999)
- "Multidrug resistance and malignancyin human osteosarcoma", 56, pp.2434~2439 (1996)
- "Phenylacetic acid in human body fluids:high correlationbetween plasma and cerebrospinal fluid concentration values", 45, pp.366~368 (1982)
- "Phenylacetate:a novel nontoxicinducer of tumor cell differentiation", 52, pp.1988~1992 (1992)
- "Selective growth arrest andphenotypic reversion of prostate cancer cells in vitro by nontoxicpharmacological concentrations of phenylacetate", 91, pp.2288~2295 (1993)
- "Tumor growth inhibition,apoptosis,and Bc1-2 down-regulation of MCF-7ras tumors by sodiumphenylacetate and tamoxifen combination", 57, pp.1023~1029 (1997)
- "Phenylacetate inhibits isoprenoid biosynthesis and suppressesgrowth of human pancreatic carcinoma", 124, pp.541~550 (1998)
- "Effects of phenylacetate oncells from patients with B-chronic lymphocytic leukemia", 14, pp.145~149 (1994)
- "Growth inhibitory effects of sodium phenylacetate(NSC3039) on ovarian carcinoma cells in vitro", 57, pp.4309~4315 (1997)
- "Inhibition of proliferation and inductionof differentiation in medulloblastoma- and astrocytomaderivedcell lines with phenylacetate", 83, pp.672~681 (1995)
- "Apoptosis and thecell cycle", 40, pp.603~612 (1994)
- "Multiple Bcl-2 family members demonstrateselective dimerizations with Bax", 92, pp.7834~7838 (1995)
- "Sodium phenylacetateinduces growth inhibition and Bcl-2 down- regulation andapoptosis in MCF7ras cells in vitro and in nude mice", 55, pp.5156~5160 (1995)
- "Mammalian G1 cyclins", 73, pp.1059~1065 (1993)
- "The retinoblastoma protein and cell cycle control", 81, pp.323~330 (1995)
- "Phenylacetate inhibits growthand modulates cell cycle gene expression in renal cancer celllines", 23, pp.1637~1642 (2003)
- "p27Kip1 is the key mediator of phenylacetate induced cellcycle arrest in human prostate cancer cells", 20, pp.3075~3081 (2000)
- "Glutamine and glucose asenergy substrates for Ehrlich ascites tumour cells", 16, pp.339~347
- "Regulation of the mevalonate pathway", 343, pp.425~430 (1990)
- "The essentials of DNA methylation", 70, pp.5~8 (1992)
- "Stimulation of adipogenesisin fibroblasts by PPAR gamma 2,a lipid-activated transcriptionfactor", 79, pp.1147~1156 (1994)
- "DRTF1", E2F:an expanding family of heterodimerictranscription factors implicated in cell-cycle control, 1994, pp.19, 108~114
- "Human cyclin E,a nuclear protein essential for theG1-to-S phase transition", 15, pp.2612~2624 (1995)
- "Upregulationand functional role of p21Waf1", Cip1 during growtharrest of human breast carcinoma MCF-7 cells by phenylacetate, 1996, pp.7, 1609~1615
